Athersys Limited

Overview

Legal name

ATHERSYS LIMITED

Region

Scotland

Registered address

Unknown

Insolvency history

No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller

1

Company Active LTD

Athersys Limited

CRN SC302032

2

Direct and ultimate controller

DE 3981772

CRN DE 3981772

Company events

Reference milestones and recent Companies House filing stream events.

1 event

08 May

2006

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards

First funded

2010

Funded years

2010, 2015

Age at first award

4 years

Projects

2015 Collaborative R&D Lead participant

MultiStem for the Treatment of Acute Respiratory Distress Syndrome

1 Apr 2015 to 31 Mar 2018

Awarded

£750,000

Total cost £1,249,999

MUST-ARDS (MultiStem® for the Treatment of Acute Respiratory Distress Syndrome) is a phase 1/2 clinical trial designed to investigate a novel adult cell therapy for ARDS. MultiStem is an allogeneic, adult, multipotent progenitor stem cell that is currently being investigated in phase 2 clinical trials to treat ischemic stroke and ulcerative colitis. Ather...

2010 Fast Track

Preparation for Evaluation of a diabetes interventional cell therapy

1 Jul 2010 to 30 Apr 2011

Awarded

£87,000

Total cost £165,000

Awaiting Public Summary

Product types

Collaborative R&D Fast Track